In 2022, the Office of Technology Transfer at the National Institutes of Health (NIH) engaged RTI International, a nonprofit research institute, to develop new methods for characterizing and measuring the impact of technologies developed by NIH’s Intramural Research Program. The RTI team created models to illustrate how technologies licensed from NIH to firms contribute to the stimulation of the U.S. biomedical innovation system, economic activity, and national and global public health.

This presentation, hosted by the LES USA-Canada DC Chapter, will discuss the results of the project and show the true value of a patent & licensing program and its full range of impacts over the course of more than 30 years of technology transfer activity.